C
Christopher J. Crnich
Researcher at University of Wisconsin-Madison
Publications - 117
Citations - 5090
Christopher J. Crnich is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Medicine & Antimicrobial stewardship. The author has an hindex of 24, co-authored 104 publications receiving 4525 citations. Previous affiliations of Christopher J. Crnich include Veterans Health Administration & University of Virginia.
Papers
More filters
Journal ArticleDOI
The Risk of Bloodstream Infection in Adults With Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies
TL;DR: These data, based on prospective studies of adults, show that all types of IVDs pose a risk of IVD-related BSI and can be used for benchmarking rates of infection caused by the various types of intravascular devices in use at the present time.
Journal Article
The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention.
TL;DR: Routine surveillance of VAPs is mandatory, and high-risk patients, especially those with prolonged granulocytopenia or organ transplants, should be cared for in hospital units with high-efficiency-particulate-arrestor filtered air.
Journal ArticleDOI
Surveillance Definitions of Infections in Long-Term Care Facilities: Revisiting the McGeer Criteria
Nimalie D. Stone,Muhammad Salman Ashraf,Jennifer Ann Marie Calder,Christopher J. Crnich,Kent B. Crossley,Paul J. Drinka,Carolyn V. Gould,Manisha Juthani-Mehta,Ebbing Lautenbach,Mark Loeb,Taranisia MacCannell,Preeti N. Malani,Lona Mody,Joseph M. Mylotte,Lindsay E. Nicolle,Mary Claire Roghmann,Steven J. Schweon,Andrew E. Simor,Philip W. Smith,Kurt B. Stevenson,Suzanne F. Bradley +20 more
TL;DR: Infection surveillance definitions for long-term care facilities (ie, the McGeer Criteria) have not been updated since 1991 are modified on the basis of a structured review of the literature.
Journal ArticleDOI
The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices.
TL;DR: The development of novel technologies, which are based on an understanding of pathogenesis, promises a quantum reduction in IVD-related infections in an era of growing nursing shortages, and more-effective cutaneous antiseptics have all been shown to reduce the risk of IVd-related BSI in prospective randomized trials.
Journal ArticleDOI
The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. II. Long-Term Devices
TL;DR: The development of novel technologies based on the understanding of pathogenesis promises a quantum reduction in IVD-related infections in an era of growing nursing shortage and the challenge for the future will be to identify new preventative technologies and to more-widely adapt those technologies that have been shown to be efficacious and cost effective.